Results 181 to 190 of about 28,618 (205)

CD39-CD73-adenosine effects in Sézary syndrome

Blood, 2023
Sean Whittaker, Christine L. Jones
openaire   +2 more sources

A2AR limits IL-15-induced generation of CD39+ NK cells with high cytotoxicity

International Immunopharmacology, 2023
Xueqin Zhao, Longxiang Tao, Jingjing Cong   +2 more
exaly  

CD39

1997
A. Neil Barclay, Marion H. Brown, S.K. Alex Law, Andrew J. McKnight, Michael G. Tomlinson, P. Anton van der Merwe   +5 more
openaire   +1 more source

The CD39+ HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8+ T cells exhibit potent anti-HCC activity

Molecular Therapy, 2021
Fan Zou, Jizhou Tan, Ting Liu
exaly  

CD39 pathway inhibits Th1 cell function in tuberculosis

Immunology, 2022
Ying Xue, Guoxing Tang, Huijuan Song
exaly  

CD39

2000
Clare M. Isacke, Michael A. Horton
openaire   +1 more source

CD39 Expression in Mesenchymal Stromal Cells

Journal of Immunotherapy, 2011
Felipe, Saldanha-Araujo, Rodrigo A, Panepucci   +1 more
openaire   +2 more sources

The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation

Journal of Autoimmunity, 2015
Anne Rissiek, Angelica Cuapio, Hans-Willi Mittrücker   +2 more
exaly  

CD39

2018
openaire   +1 more source

Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies

Cell Reports, 2019
Henri-Alexandre Michaud, Laurent Gros, Cecile Dejou   +2 more
exaly